Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: Evidence that 6-iodolactone mediates apoptotic effects

Endocrine-Related Cancer

Volumn 15, Issue 4, 2008, Pages 1003-1011

  Arroyo Helguera, O ^a   Rojas, E ^b   Delgado, G ^a   Aceves, C ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

6 IODOLACTONE; APOPTOSIS INDUCING FACTOR; ARACHIDONIC ACID DERIVATIVE; CASPASE; IODINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; SIGNAL TRANSDUCTION;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; ARACHIDONIC ACID; BREAST; BREAST NEOPLASMS; CASPASES; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOBLOTTING; IODINE; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION;

EID: 58249112933     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0125     Document Type: Article

References (38)

1. Aceves C, Anguiano B & Delgado G 2005 Is iodine a gatekeeper of the integrity of the mammary gland? Journal of Mammary Gland Biology and Neoplasia 10 189-196.
2. Anguiano B, Garcia-Solis P, Delgado G & Aceves C 2007 Uptake and gene expression with antitumoral doses of iodine in thyroid and mammary gland: evidence that chronic administration has not harmful effects. Thyroid 17 851-859.
3. Arroyo-Helguera O, Rodriguez-Hernández A, Aguilar MB & Aceves C 2006a Identificación de la 6-yodo-delta-lactona (6-IL) en glándula mamaria (GM) de rata tratada crónicamente con yodo molecular (I2) y su efecto citotóxico en líneas celulares tumorales y no tumorales mamarias humanas. Sociedad Mexicara de Bioquímica XXVI Congreso National. Guarajuato, Mexico. Abstract 145.
4. Arroyo-Helguera. O, Anguiano B, Delgado G & Aceves C 2006b Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocrine-Related Cancer 13 1147-1158.
5. Berger J & Moller DE 2002 The mechanisms of action of PPAR. Annual Review of Medicine 53 409-435.
6. Boeynaems JM & Hubbard WC 1980 Transformation of arachidonic acid into an iodolactone by the rat thyroid. Journal of Biological Chemistry 255 9001-9004.
7. Claria J 2006 Regulation of cell proliferation and apoptosis by bioactive lipid mediators. Recent Patents on Anti-Cancer Drug Discovery 1 369-382.
8. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS & Carrasco N 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews 24 48-77.
9. Dugrillon A, Uedelhoven WM, Pisarev MA, Bechtner G & Gartner R 1994 Identification of delta-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles. Hormone Metabolic Research 26 465-469.
10. Elstner E, Müller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D & Koeffler HP 1998 Ligands for peroxisome proliferator - activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. PNAS 95 8806-8811.
11. Eskin BA, Grotkowski CE, Connolly CP & Ghent WR 1995 Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biological Trace Element Research 49 9-19.
12. Funahashi H, Imai T, Tanaka Y, Tobinaga J, Wada M, Morita T, Yamada F, Tsukamura. K, Oiwa M, Kikumori T et al. 1996 Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. Journal of Surgical Oncology 61 209-213.
13. Garcia-Solis P, Alfaro Y, Anguiano B, Delgado G, Guzman RC, Nandi S, Diaz-Munoz M, Vazquez/Martinez O & Aceves C 2005 Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I -) treatment Evidence that I2 prevents cancer promotion. Molecular and Cellular Endocrinology 236 49-57.
14. Ghent WR, Eskin BA, Low DA & Hill LP 1993 Iodine replacement in fibrocystic disease of the breast. Canadian Journal of Surgery 36 453-460.
15. Joanta AE, Filip A, Clichici S, Andrei S & Daicoviciu D 2006 Iodide excess exerts oxidative stress in some target tissues of the thyroid hormones. Acta Physiologica Hungarica 93 347-359.
16. Kessler JH 2004 The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia. Breast Journal 10 328-336.
17. Langer R, Burzler C, Bechtner G & Gartner R 2003 Influence of iodide and iodolactones on thyroid apoptosis. Evidence that apoptosis induced by iodide is mediated by iodolactones in intact porcine thyroid follicles. Experimental and Clinical Endocrinology and Diabetes 111 325-329.
18. Li GY & Osborne NN 2008 Oxidative-induced apoptosis to an inmortalized ganglion cell line is caspase independent but involves the activation of poly(ADP-ribose)polymerase and apoptosis-inducing factor. Brain Research 1188 35-43.
19. Mutaku JF, Poma J-F, Many M-C, Denef J-F & van den Hove M-F 2002 Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. Journal of Endocrinology 172 375-386.
20. Nevins JR, Chellappan SP, Mudryj M, Hiebert S, Devoto S, Horowitz J, Hunter T & Pines J 1991 E2F transcription factor is a target for the RB protein and the cyclin A protein. Cold Spring Harbor Symposia on Quantitative Biology 56 157-162.
21. Nuñez-Anita RE, Arroyo-Helguera O, Cajero-Juárez M, López-Bojorquez L & Aceves C 2007 6-Iodo-δ-lactone identified as novel ligand of peroxisome proliferator-activated receptors (PPARs). 78th Annual Meeting of The American Thyroid Association, New York, USA, October. Abstract 42.
22. Oltvai ZN, Milliman CL & Korsmeyer SJ 1993 Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 609-619.
23. Pisarev MA & Gartner R 2000 Autoregulatory actions of iodine. In Werner and Ingbar's The Thyroid. A Fundamental and Clinical Text, pp 85-90. Eds LE Braverman & R Utiger, Edn 8 Philadelphia, PA, USA: Lippincott Williams & Wilkins.
24. Pisarev MA, Krawiec L, Juvenal GJ, Bocanera LV, Pregliasco LB, Sartorio G & Ghester RA 1994 Studies on the goiter inhibiting action of iodolactones. European Journal of Pharmacology 258 33-37.
25. Reed JC 1997 Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. Advances in Pharmacology 41 501-532.
26. Rillema JA & Mulder JA 1978 Arachidonic acid distribution in lipids of mammary glands and DMBA-induced tumors of rats. Prostaglandins and Medicine 1 31-38.
27. Roninson IB 2002 Oncogenic functions of tumour suppressor p21(Waf1/Cip1/ Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Letters 179 1-14.
28. Shah NM, Eskin BA, Krouse TB & Sparks CE 1986 Iodoprotein formation by rat mammary glands during pregnancy and early postpartum period. Proceedings of the Society for Experimental Biology and Medicine 181 443-449.
29. Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A & Godbole MM 2006 Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. Journal of Biological Chemistry 281 19762-19771.
30. Smerdely P, Pitsiavas V & Boyages SC 1993 Evidence that the inhibitory effects of iodide on thyroid cell proliferation are due to arrest of the cell cycle at G0-G1 and G2M phases. Endocrinology 133 2881-2888.
31. Smyth PPA 2003 Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 19 121-130.
32. Upadhyay G, Singh R, Sharma R, Balapure AK & Godbole MM 2002 Differential action of iodine on mitochondria from human tumoral-and extra-tumoral tissue in inducing the release of apoptogenic proteins. Mitochondrion 2 199-210.
33. Venturi S 2001 Is there a role for iodine in breast diseases? Breast 10 379-382.
34. Virag L 2005 Structure and function of poly(ADP-ribose) polymerase-1. Role in oxidative stress related pathologies. Current Vascular Pharmacology 3 209-214.
35. Vitale M, Matola TD & D'Ascoll F 2000 Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141 598-605.
36. Yamauchi A & Bloom ET 1997 Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood 89 4092-4099.
37. Yu SW, Wang H, Poitras MF, Coombs C, Federoff HJ, Poirier GG, Dawson TM & Dawson VL 2002 Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 259-263.
38. Zamzami N & Kroemer G 2001 The mitochondrion in apoptosis: how Pandora's box opens. Nature Reviews. Molecular Cell Biology 2 67-71.